Zone 2 lidocaine cream recalled because stability data does not support expiry
HTO Nevada, trading as Kirkman, is recalling one lot of Maximum Zone 2 4% Lidocaine Cream because the stability data does not support the labeled expiry date.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Rubric level 2 covers minor labelling errors: the fault is an expiry date the stability data does not support, and the source describes no hazard, illness or injury.
Plain-English summary
HTO Nevada Inc., trading as Kirkman, is recalling MAXIMUM ZONE 2 4% Lidocaine Cream (Lidocaine 4% and Epinephrine 0.01%) in 1 oz bottles, distributed by Dermal Source of Portland, Oregon, NDC 80069-015. About 243 bottles were distributed nationwide within the United States. The FDA has classified this recall as Class II.
The recall was initiated because the stability data does not support the expiry date. The source record does not describe a specific hazard, illness or injury.
Affected product is lot 795CP-0005 with an expiry date of 06/30/2026.
Users can identify affected product by the NDC and lot number above, and may contact HTO Nevada Inc. for further information.
The recalled product
- Product
- MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015.
- Manufacturer
- HTO Nevada Inc. dba Kirkman
- Category
- Drug — Topical anaesthetic
- Affected units
- 243
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 795CP-0005
- Exp. Date 06/30/2026
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by HTO Nevada Inc. dba Kirkman under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · HTO Nevada Inc. dba Kirkman
See all →- ModerateVasocaine lidocaine spray recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateZone 1 lidocaine cream recalled because stability data does not support expiry
FDA (Drugs) · 2026-03-11
- ModerateDietary Supplement Labeling Error: Kirkman 5-MTHF Folic Acid Misdeclared
FDA (Food) · 2024-05-15
Same hazard · stability failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateCisatracurium 200 mg vials recalled after subpotent stability assay results
FDA (Drugs) · 2025-12-24
- ModerateCiclopirox shampoo recalled after failing impurity specifications at eighteen months
FDA (Drugs) · 2025-12-24
- ModerateCisatracurium 20 mg multiple-dose vials recalled after subpotent assay results
FDA (Drugs) · 2025-12-24
- ModerateCisatracurium 10 mg vials recalled after subpotent stability assay results
FDA (Drugs) · 2025-12-24